NIH-funded research R01 grant

Understanding how tuberculosis bacteria use carbon during infection

Official title: M. tuberculosis carbon metabolism during infection

Funded at Weill Medical Coll of Cornell Univ · NIH-11086637 · Data updated 2026-11-12

This study is looking at how the bacteria that cause tuberculosis use different types of carbon in the body during infection, and it's for anyone interested in finding new treatments for tuberculosis by understanding how these bacteria survive and grow.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJune 2, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$817,108
NIH project number5R01AI177560-03
Project IDNIH-11086637 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with active or chronic tuberculosis infections.

Less likely to help

Patients who do not have tuberculosis or are not currently infected with the bacteria will not benefit from this research.

What this research studies

This research investigates how the bacteria causing tuberculosis (M. tuberculosis) utilize carbon in different environments within the body during infection. By using animal models, including nonhuman primates and mice, the study aims to identify specific enzymes involved in the bacteria's metabolism that could serve as targets for new tuberculosis drugs. The researchers will manipulate these enzymes to observe their role in establishing and maintaining infection, particularly under various conditions that mimic human disease. This approach could lead to a better understanding of how tuberculosis persists and progresses in the body.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective treatments for tuberculosis, potentially reducing the burden of this disease.

How similar studies have gone: Other research has shown promise in targeting bacterial metabolism for drug development, indicating that this approach could be effective.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Ehrt, Sabine — Weill Medical Coll of Cornell Univ
  • Study coordinator: Ehrt, Sabine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.